Levosert Shi

Levonorgestrel, the active ingredient in Levosert Shi, is a progestin presented as an intrauterine system for intrauterine use. The device releases levonorgestrel locally over up to three years, providing long‑acting reversible contraception for women of reproductive age.

GNH USA supplies Levosert Shi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for regulated distribution and quality‑assured logistics. The company adheres to global regulatory standards and provides support for import documentation and cold‑chain management where required.

Levosert Shi, a levonorgestrel intrauterine system, is used within the hormonal contraceptive pathway to prevent pregnancy.

Contraception (Long‑acting reversible contraceptive): Provides highly effective pregnancy prevention for up to three years after insertion. Management of heavy menstrual bleeding: Reduces menstrual blood loss and can improve anemia associated with heavy periods.

Levosert Shi may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Irregular vaginal bleeding or spotting - Pelvic or abdominal cramping - Breast tenderness

Serious or Rare Side Effects: - Uterine perforation during insertion - Device expulsion or displacement - Pelvic inflammatory infection

Before using Levosert Shi, several precautions should be observed to ensure safety and effectiveness.

Pregnancy testing: Confirm patient is not pregnant before insertion. Timing of insertion: Place device within the first five days of menstrual cycle to ensure no existing pregnancy. Uterine evaluation: Assess for fibroids, congenital anomalies, or active infection prior to placement. Infection risk: Treat any active pelvic infection before procedure. Follow‑up examination: Schedule a check-up 4–6 weeks after insertion to verify correct positioning. Store at below 25°C: Keep in original packaging, protect from moisture and direct sunlight.

Levosert Shi can interact with other medicines that affect hormone metabolism or efficacy.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) that lower levonorgestrel levels. - Antiepileptic drugs that increase hepatic metabolism of levonorgestrel.

Moderate Interactions (Monitor Closely): - Certain antifungal agents (ketoconazole) that may increase levonorgestrel exposure. - HIV protease inhibitors (ritonavir) that can alter hormone levels. - Antibiotics such as tetracycline that may affect contraceptive efficacy.